UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s share price was down 0.9% during trading on Thursday . The company traded as low as $526.56 and last traded at $528.87. Approximately 1,636,398 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 3,936,696 shares. The stock had previously closed at $533.53.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Cantor Fitzgerald increased their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Barclays increased their price target on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Finally, Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $626.84.
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Price Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the business earned $6.56 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.
Institutional Investors Weigh In On UnitedHealth Group
Several large investors have recently bought and sold shares of the stock. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $27,000. Macroview Investment Management LLC grew its holdings in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Signature Resources Capital Management LLC grew its stake in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the last quarter. Finally, West Financial Advisors LLC purchased a new stake in UnitedHealth Group in the third quarter valued at approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is the Euro STOXX 50 Index?
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Best Aerospace Stocks Investing
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
- How to Invest in the FAANG Stocks
- Intel Stock: A Value Play in the Quantum Computing Space
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.